ATS 2018 International Conference - Mobile

Paul Rowe

MD

Sanofi

Session(s)

Type 2 Biomarkers Associated with Dupilumab Efficacy in Patients with Uncontrolled, Modera...
Tuesday, May 22 2:15 PM - 4:15 PM
Dupilumab Treatment Produces Rapid and Sustained Improvements in FEV1 in Patients with Unc...
Wednesday, May 23 9:30 AM - 9:45 AM